The homing of prostate cancer to bone in vivo is modulated by Zoledronic acid

Author(s):
Reeves, K.J.; Cecchini, M.G.; Pluijm, G. van der (0000-0002-1351-1884); Eaton, C.L.; Hamdy, F.C.; Brown, N.J.
Published
2011
Publication type
Article / Letter to editor
Date issued
2011-01-01
Language
English
Is part of
BONE (2011), Vol. 48, no. 1, p. S45-S46
hdl
1887/117952
doi
10.1016/j.bone.2010.10.128